DE69624047T2 - Im unteren Teil des Verdauungstrakts freisetzende pharmazeutische Zubereitung in Form einer beschichteten Kapsel - Google Patents
Im unteren Teil des Verdauungstrakts freisetzende pharmazeutische Zubereitung in Form einer beschichteten KapselInfo
- Publication number
- DE69624047T2 DE69624047T2 DE69624047T DE69624047T DE69624047T2 DE 69624047 T2 DE69624047 T2 DE 69624047T2 DE 69624047 T DE69624047 T DE 69624047T DE 69624047 T DE69624047 T DE 69624047T DE 69624047 T2 DE69624047 T2 DE 69624047T2
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical preparation
- digestive tract
- low
- polymer film
- coated capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18365595 | 1995-07-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69624047D1 DE69624047D1 (de) | 2002-11-07 |
DE69624047T2 true DE69624047T2 (de) | 2003-08-14 |
Family
ID=16139614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69624047T Expired - Fee Related DE69624047T2 (de) | 1995-07-20 | 1996-07-18 | Im unteren Teil des Verdauungstrakts freisetzende pharmazeutische Zubereitung in Form einer beschichteten Kapsel |
Country Status (13)
Country | Link |
---|---|
US (1) | US6309666B1 (de) |
EP (1) | EP0754452B1 (de) |
KR (1) | KR100389602B1 (de) |
CN (1) | CN1076964C (de) |
AT (1) | ATE225165T1 (de) |
CA (1) | CA2181502C (de) |
DE (1) | DE69624047T2 (de) |
DK (1) | DK0754452T3 (de) |
ES (1) | ES2184846T3 (de) |
ID (1) | ID17428A (de) |
PT (1) | PT754452E (de) |
SG (1) | SG80553A1 (de) |
TW (1) | TW514533B (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004046102A1 (de) * | 2004-09-23 | 2006-04-06 | Mars Inc. | Indikatorgranulat |
US10653631B2 (en) | 2011-09-07 | 2020-05-19 | Roland SAUR-BROSCH | Optimal colon targeting technology |
US10799460B2 (en) | 2011-09-07 | 2020-10-13 | Roland SAUR-BROSCH | Formulation for the controlled release of one or several substances in the digestive tract of a mammal |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL336231A1 (en) * | 1997-02-13 | 2000-06-19 | Bone Care International | System for aimed therapeutic delivery of vitamin d compounds |
US20030129194A1 (en) * | 1997-02-13 | 2003-07-10 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin D compounds |
US20020035071A1 (en) * | 1997-07-08 | 2002-03-21 | Josef Pitha | Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites |
US20060116330A1 (en) * | 1997-07-08 | 2006-06-01 | The Iams Company | Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose |
US8563522B2 (en) * | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
US6303144B1 (en) | 1998-02-10 | 2001-10-16 | Welfide Corporation | Preparations with controlled release |
UA69413C2 (uk) | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
US7122207B2 (en) | 1998-05-22 | 2006-10-17 | Bristol-Myers Squibb Company | High drug load acid labile pharmaceutical composition |
UA73092C2 (uk) | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
AU5758799A (en) * | 1998-09-25 | 2000-04-17 | Sankyo Company Limited | Hmg-coa reductase inhibitor-containing preparations |
AU757343B2 (en) * | 1998-09-28 | 2003-02-20 | Capsugel Belgium Nv | Enteric and colonic delivery using HPMC capsules |
JP2000247911A (ja) | 1999-02-26 | 2000-09-12 | Hisamitsu Pharmaceut Co Inc | 大腸用吸収促進剤 |
EP1197228A4 (de) | 1999-07-02 | 2004-03-10 | Hisamitsu Pharmaceutical Co | Arzneimittel für die behandlung von kolorektalem krebs |
AU2001234005B2 (en) * | 2000-02-28 | 2006-01-19 | Pharmakodex Limited | Improvements in or relating to the delivery of oral drugs |
TWI241195B (en) * | 2000-04-10 | 2005-10-11 | Shionogi & Co | Preventive agent for bile acidic diarrhea |
KR100838686B1 (ko) | 2000-06-16 | 2008-06-16 | 미쯔비시 웰 파마 가부시키가이샤 | 방출 pH 범위 및/또는 속도 제어 조성물 |
GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
US7883721B2 (en) * | 2001-01-30 | 2011-02-08 | Smithkline Beecham Limited | Pharmaceutical formulation |
US7842308B2 (en) * | 2001-01-30 | 2010-11-30 | Smithkline Beecham Limited | Pharmaceutical formulation |
US7316819B2 (en) * | 2001-03-08 | 2008-01-08 | Unigene Laboratories, Inc. | Oral peptide pharmaceutical dosage form and method of production |
US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
US20030044458A1 (en) | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
JP4031232B2 (ja) * | 2001-11-09 | 2008-01-09 | カプスゲル・ジャパン株式会社 | 新規カプセル |
US7101565B2 (en) | 2002-02-05 | 2006-09-05 | Corpak Medsystems, Inc. | Probiotic/prebiotic composition and delivery method |
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
US6982253B2 (en) * | 2002-06-05 | 2006-01-03 | Supergen, Inc. | Liquid formulation of decitabine and use of the same |
US8168170B2 (en) * | 2002-10-03 | 2012-05-01 | The Procter And Gamble Company | Compositions having an inner core and at least three surrounding layers |
MY148805A (en) * | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
US7320583B2 (en) * | 2003-04-16 | 2008-01-22 | Frito-Lay North America, Inc | Apparatus and method for producing colored extruded food products |
TW200526274A (en) * | 2003-07-21 | 2005-08-16 | Smithkline Beecham Plc | Pharmaceutical formulations |
GB0320522D0 (en) | 2003-09-02 | 2003-10-01 | Glaxo Group Ltd | Formulation |
US8894991B2 (en) * | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
US20050158294A1 (en) * | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
US20050152884A1 (en) * | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
US8877178B2 (en) * | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
TW200539903A (en) | 2004-03-12 | 2005-12-16 | Smithkline Beecham Plc | Pharmaceutical formulations |
US20050283097A1 (en) * | 2004-06-18 | 2005-12-22 | Ultrastop Ltd. | Devices and methodologies useful in non invasive termination of pregnancy |
GB0427456D0 (en) * | 2004-12-15 | 2005-01-19 | Phoqus Pharmaceuticals Ltd | Formulation for production of capsule shells and capsules |
BRPI0611492B1 (pt) * | 2005-05-31 | 2021-10-13 | Mars, Incorporated | Bifidobactéria probiótica felina |
AU2006253006B8 (en) * | 2005-05-31 | 2011-09-15 | Alimentary Health Ltd | Feline probiotic Lactobacilli |
US20070014847A1 (en) * | 2005-07-05 | 2007-01-18 | Ahmed Salah U | Coated capsules and methods of making and using the same |
US20070196399A1 (en) * | 2006-02-21 | 2007-08-23 | Shin-Etsu Chemical Co., Ltd. | Enteric-coated preparation covered with enteric coating material for site-specific delivery of drug to site within the small intestine |
MX2009008166A (es) | 2007-02-01 | 2009-08-12 | Iams Company | Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate. |
KR101569604B1 (ko) | 2007-12-28 | 2015-11-16 | 임팩스 라보라토리즈, 인코포레이티드 | 레보도파 방출 제어형 제제 및 이의 용도 |
GB0808537D0 (en) | 2008-05-12 | 2008-06-18 | Archimedes Dev Ltd | Compositions |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
WO2010080730A2 (en) * | 2009-01-09 | 2010-07-15 | Mayo Foundation For Medical Education And Research | Methods and materials for delivering bile acids |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
JP6027532B2 (ja) * | 2010-08-25 | 2016-11-16 | セカンド、グラント、ルーファス スパーリング | 改良された腸溶性の活性物質送達 |
DE102011082716A1 (de) * | 2011-09-14 | 2013-03-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Indikatorelement mit einer von einer in kontakt zu bringenden substanz abhängigen farbgebung |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
EP3782614A1 (de) * | 2013-10-07 | 2021-02-24 | Impax Laboratories, LLC | Mukoadhäsive levodopa-formulierungen mit gesteuerter freisetzung und/oder levodopa-ester und verwendungen davon |
WO2017175752A1 (ja) | 2016-04-08 | 2017-10-12 | 株式会社ダイセル | セルロースエステルとその成形体 |
EP3485879A1 (de) * | 2017-11-17 | 2019-05-22 | Maat Pharma | Orale pharmazeutische formulierung enthaltend bakterien |
CA3098604A1 (en) * | 2018-05-03 | 2019-11-07 | M.W. Encap Limited | Dosage forms for delivery of medicines to the lower gastrointestinal tract |
US20210369625A1 (en) * | 2018-10-02 | 2021-12-02 | Qualicaps Co., Ltd. | Improved-strength hard capsule and production method for same |
KR102106244B1 (ko) * | 2019-10-30 | 2020-05-04 | 한국광기술원 | 앵커를 구비하는 캡슐형 광역학 치료장치 |
US11896719B2 (en) | 2022-01-24 | 2024-02-13 | Calliditas Therapeutics Ab | Pharmaceutical compositions |
WO2023174722A1 (en) * | 2022-03-15 | 2023-09-21 | Evonik Operations Gmbh | Pre-functionalized hard shell capsule with accelerated drug release at ph value 5 to 5.5 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4012444A (en) * | 1969-07-08 | 1977-03-15 | Allen & Hanburys Limited | 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof |
US5188840A (en) * | 1985-09-26 | 1993-02-23 | Chugai Seiyaku Kabushiki Kaisha | Slow-release pharmaceutical agent |
JPS6299322A (ja) | 1985-10-24 | 1987-05-08 | Shinjiro Tsuji | 硬カプセル剤の新しい剤形 |
IL77186A0 (en) * | 1985-11-29 | 1986-04-29 | Touitou Elka | Pharmaceutical insulin composition |
DE3812799A1 (de) * | 1988-04-16 | 1989-10-26 | Sanol Arznei Schwarz Gmbh | Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung |
US5252576A (en) * | 1988-07-18 | 1993-10-12 | Yamasa Shoyu Kabushiki Kaisha | 1-amino-5-halogenouracils, process for their preparation, and central nervous system depressants containing same as active ingredient |
ES2062527T3 (es) * | 1989-05-11 | 1994-12-16 | Chugai Pharmaceutical Co Ltd | Preparacion oral que puede ser liberada en una region apropiada del intestino. |
JPH0674206B2 (ja) * | 1989-12-28 | 1994-09-21 | 田辺製薬株式会社 | 放出制御型製剤およびその製法 |
JP2773959B2 (ja) * | 1990-07-10 | 1998-07-09 | 信越化学工業株式会社 | 大腸内放出性固形製剤 |
JP3122478B2 (ja) | 1991-02-19 | 2001-01-09 | 帝國製薬株式会社 | 下部消化管放出型経口製剤 |
JPH0624962A (ja) | 1992-07-09 | 1994-02-01 | Green Cross Corp:The | 腸溶徐放性製剤 |
ES2119818T3 (es) | 1992-08-13 | 1998-10-16 | Teikoku Seiyaku Kk | Preparacion oral para liberacion en el tracto digestivo inferior. |
WO1994010983A1 (en) | 1992-11-06 | 1994-05-26 | Hisamitsu Pharmaceutical Co., Inc. | Peroral pharmaceutical preparation releasable in lower digestive tract |
JPH06256166A (ja) | 1993-01-06 | 1994-09-13 | ▲寛▼治 ▲高▼田 | 薬物放出制御製剤 |
JPH0710745A (ja) | 1993-06-22 | 1995-01-13 | Tanabe Seiyaku Co Ltd | 放出開始時間制御型腸デリバリー経口製剤 |
-
1996
- 1996-07-13 SG SG9610256A patent/SG80553A1/en unknown
- 1996-07-15 US US08/680,753 patent/US6309666B1/en not_active Expired - Fee Related
- 1996-07-18 DK DK96401604T patent/DK0754452T3/da active
- 1996-07-18 ES ES96401604T patent/ES2184846T3/es not_active Expired - Lifetime
- 1996-07-18 EP EP96401604A patent/EP0754452B1/de not_active Expired - Lifetime
- 1996-07-18 PT PT96401604T patent/PT754452E/pt unknown
- 1996-07-18 CA CA002181502A patent/CA2181502C/en not_active Expired - Fee Related
- 1996-07-18 AT AT96401604T patent/ATE225165T1/de not_active IP Right Cessation
- 1996-07-18 DE DE69624047T patent/DE69624047T2/de not_active Expired - Fee Related
- 1996-07-19 KR KR1019960029252A patent/KR100389602B1/ko not_active IP Right Cessation
- 1996-07-19 TW TW085108781A patent/TW514533B/zh not_active IP Right Cessation
- 1996-07-22 ID IDP962071A patent/ID17428A/id unknown
- 1996-07-22 CN CN96107185A patent/CN1076964C/zh not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004046102A1 (de) * | 2004-09-23 | 2006-04-06 | Mars Inc. | Indikatorgranulat |
DE102004046102B4 (de) * | 2004-09-23 | 2009-09-03 | Mars Inc. | Indikatorgranulat |
US7670845B2 (en) | 2004-09-23 | 2010-03-02 | Mars Incorporated | Indicator granular material |
US10653631B2 (en) | 2011-09-07 | 2020-05-19 | Roland SAUR-BROSCH | Optimal colon targeting technology |
US10799460B2 (en) | 2011-09-07 | 2020-10-13 | Roland SAUR-BROSCH | Formulation for the controlled release of one or several substances in the digestive tract of a mammal |
Also Published As
Publication number | Publication date |
---|---|
ID17428A (id) | 1997-12-24 |
ES2184846T3 (es) | 2003-04-16 |
DK0754452T3 (da) | 2003-02-03 |
EP0754452A2 (de) | 1997-01-22 |
DE69624047D1 (de) | 2002-11-07 |
MX9602863A (es) | 1997-09-30 |
CN1142944A (zh) | 1997-02-19 |
SG80553A1 (en) | 2001-05-22 |
EP0754452A3 (de) | 1998-01-21 |
PT754452E (pt) | 2003-02-28 |
CA2181502C (en) | 2003-02-11 |
CA2181502A1 (en) | 1997-01-21 |
US6309666B1 (en) | 2001-10-30 |
CN1076964C (zh) | 2002-01-02 |
ATE225165T1 (de) | 2002-10-15 |
KR970005279A (ko) | 1997-02-19 |
TW514533B (en) | 2002-12-21 |
KR100389602B1 (ko) | 2003-09-29 |
EP0754452B1 (de) | 2002-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69624047D1 (de) | Im unteren Teil des Verdauungstrakts freisetzende pharmazeutische Zubereitung in Form einer beschichteten Kapsel | |
DK0673645T3 (da) | Farmaceutisk præparat til afgivelse af lægemidler i colon | |
DE3686936D1 (de) | Am zielorgan wirkendes enterales abgabesystem. | |
MX9500885A (es) | Preparacion farmaceutica para administracion oral. | |
BR0315142A (pt) | Cápsula, tablete, grânulo ou grânulo fino, e, cápsula de liberação prolongada | |
ATE251899T1 (de) | Pharmazeutische dosierungsform zur freisetzung im colon | |
IE872110L (en) | Oral therapeutic system having systemic action | |
HU912170D0 (en) | Medical preparations for providing controlled feeling of release | |
DE69619668T2 (de) | Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon | |
CA2383220A1 (en) | Controlled release pellet formulation | |
AU7534087A (en) | Sustained release pharmaceutical compositions in oral dosage form | |
ATE238774T1 (de) | Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt | |
ATE235232T1 (de) | Lutschtablette zur modifizierten freisetzung von wirkstoffen im gastrointestinaltrakt | |
DE69909316D1 (de) | Pharmazeutische formulierung mit omeprazol | |
DK156289D0 (da) | Farmaceutisk praeparat indrettet til kontrolleret afgivelse af aktiv bestanddel | |
ATE198152T1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
ATE124255T1 (de) | Im dickdarm zerfallende, polypeptide enthaltende orale formulierungen. | |
DE69622850D1 (de) | Perorale zusammensetzung zur kontrollierten freisetzungen in dem unteren teil des gastrointestinaltraktes | |
SE8803822D0 (sv) | Novel dosage form | |
DE60142305D1 (de) | Pharmazeutische zubereitung enthaltend n-ä2-(1,6,7,8-tetrahydro-2h-indenoä5,4 büfuran-8-yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung | |
DE69008107T2 (de) | Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs. | |
BR9612800A (pt) | Forma de dosagem farmacêutica para distribuição colÈnica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |